The Goldman Sachs technology M&A team, led by Sam Britton, has cashed in on its software focus and decades of experience to dominate 2019's biggest deals.Technologyread more
American small and medium-size companies that rely on China are scrambling to adjust their business plans in response to the escalating trade war.Traderead more
Here are the products that stand to be the most affected by China's new tariffs on $75 billion worth of U.S. goods.Marketsread more
The summit comes amid fears over a global economic slowdown, and U.S. tensions over trade allies, Iran and Russia.Politicsread more
The world's second biggest economy is past a point where it cannot ignore its enormous debt anymore, according to an analyst.China Economyread more
Carl Medlock used to work at Tesla. Now he's one of the few people in the U.S. that can fix the company's original Roadster electric vehicles.Technologyread more
Trump does have some powerful tools that would not require approval from U.S. Congress.Politicsread more
Stocks dropped after Donald Trump ordered that U.S. manufacturers find alternatives to their operations in China.US Marketsread more
As demand for lab monkeys continues to rise, U.S. scientists are reporting delays in research projects because they can't obtain enough animals, according to the National...Politicsread more
The European Union will respond in kind if the U.S. imposes tariffs on France over digital tax plan, EU chief Donald Tusk told G-7.Technologyread more
Trump said he will raise tariffs on $250 billion in Chinese goods to 30% and hike duties on another $300 billion in products to 15%.Politicsread more
Kirkland Lake Gold: "I would actually take a little off the table. I don't see gold going anywhere right now and I keep thinking about what Warren Buffett was saying today. It made me feel like, as much as I like gold, if you have a profit in some gold, I don't think there's anything wrong with taking it. "
Prestige Brands Holdings: "It's just an also-ran company. I'm sorry. I mean, I'm happy to have them on, but there's just not enough [that's] special there. You've got to go buy a JNJ, where at least they've got some proprietary stuff in those aisles. "
CVS Health Corporation: "CVS and Walgreens – I'll give you a two-fer. Both of these stocks were down, I think, because Warren Buffett said today that it'd only be a matter of months before there would be a CEO named to the Berkshire Hathaway-J.P. Morgan-Amazon health care group and I think that's weighing on everything having to do with drugstores. "
LendingTree, Inc.: "The stock had been great and then the stock got crushed as soon as interest rates started going up. And I've got to tell you, I think [CEO] Doug Lebda has done a remarkable job, but the stock has had such a run that I wouldn't mind taking a little bit off the table, honestly. It's just been a rocket ship since we had Doug on."
Valeant Pharmaceuticals International Inc.: "Look, I think [CEO] Joe Papa's doing a good job. I mean, it's going to take a long time. They've got that big debt hoard. He's turning the thing around. It's a bit of a battleship to turn around, but I think he will do it because he's a good manager."
Nektar Therapeutics: "This is a highly speculative situation. To me, if you want cancer drugs, I'd still go with Keytruda and Merck. I think that Merck's a very inexpensive stock. Doesn't have the star power, but it does have the firepower. "
EPR Properties: "I was talking with my writing partner today. We see that stock sneaking back and we decided, you know what? We think it was overly punished, it looks like it can hold in here and I think that it's probably overdone to the downside. It's making a bottom. It yields 7.5 percent."
Iron Mountain Inc.: "Another one of these that was oversold. All these different situations – REITs have just been clobbered and I think that they're all done going down. Well, not all of them. Some of them are in trouble."
Disclosure: Cramer's charitable trust owns shares of J.P. Morgan and Amazon.